Sebi's CAS Review and the Quiet Importance of Unlisted Valuations
The news that Sebi is reviewing the 'Closing Accumulated Settlement' (CAS) methodology for derivative contract settlement prices might seem like a niche technical detail for most investors. After all, it primarily affects how futures and options contracts are priced at the end of a trading day, impacting margins and settlements. But zoom out a bit, and you see a larger, more fundamental point emerging: the regulator's focus on robust, transparent, and accurate valuation methods. And that, for our audience of HNIs and family offices, directly translates to the increasing criticality of understanding unlisted shares valuations.
Think about it. If the listed market, with its daily price discovery and massive liquidity, needs constant scrutiny on how its settlement prices are derived, how much more attention should we pay to the valuation of unlisted companies? These are companies without daily price quotes, often with limited public information, and where valuation directly dictates entry and exit prices for investors. The CAS review is a reminder that even in seemingly simple markets, valuation methodology matters. In the complex world of private equity and pre-IPO investing, it's absolutely paramount.
Why Unlisted Valuations Aren't Just 'Guesstimates'
Many investors, especially those new to private markets, sometimes view unlisted valuations as less rigorous than public market assessments. That's a mistake. While they lack the daily auction mechanism of a stock exchange, professional pre-IPO valuations employ a range of sophisticated techniques to arrive at a fair value. It's not about pulling a number out of thin air; it's about a structured, evidence-based process.
The key difference? Public market prices are driven by supply and demand, often reflecting sentiment as much as fundamentals. Unlisted valuations, conversely, are typically based on a more fundamental analysis of the business itself, its industry, growth prospects, and comparable transactions. They aim to establish an intrinsic value, which, while subjective to an extent, is derived from established financial principles.
Common Methodologies for Valuing Unlisted Entities
There isn't a single magic formula for unlisted valuations. Instead, analysts use a combination of approaches, often cross-referencing to build conviction.
Discounted Cash Flow (DCF)
This is a cornerstone. A DCF model projects a company's future free cash flows and then discounts them back to the present day using a suitable discount rate (often the Weighted Average Cost of Capital, or WACC). The idea is that a company's value is the present value of all the cash it's expected to generate over its lifetime.
- Pros: Theoretically sound, focuses on intrinsic value, flexible for various growth scenarios.
- Cons: Highly sensitive to assumptions (growth rates, discount rate, terminal value), requires detailed financial projections which can be challenging for early-stage companies.
Comparable Company Analysis (CCA) / Multiples Valuation
This method involves finding publicly traded companies (or companies that have recently been acquired) that are similar to the target unlisted company in terms of industry, business model, size, and growth profile. You then look at their valuation multiples – like Price/Earnings (P/E), Enterprise Value/EBITDA (EV/EBITDA), or Price/Sales – and apply an appropriate multiple to the unlisted company's relevant financial metric.
- Pros: Market-based, relatively straightforward to apply, reflects current market sentiment for similar businesses.
- Cons: Finding truly comparable companies can be hard, market multiples can be volatile, doesn't account for unique strategic advantages or disadvantages of the unlisted company.
Precedent Transaction Analysis (PTA)
Similar to CCA, but instead of looking at publicly traded companies, PTA examines the multiples paid in recent M&A transactions involving comparable companies. This gives insight into what strategic buyers are willing to pay for similar businesses.
- Pros: Reflects actual transaction values, often includes a control premium.
- Cons: Transactions can be infrequent, data might be less transparent, past deals might not reflect current market conditions.
Asset-Based Valuation (ABV)
Less common for high-growth tech or services companies, but relevant for asset-heavy businesses (real estate, manufacturing). This method values a company based on the fair market value of its underlying assets, minus its liabilities.
- Pros: Useful for liquidation scenarios or asset-intensive businesses.
- Cons: Doesn't capture the value of intangible assets (brand, IP, human capital) or future earning potential.
The 'Why' Behind the Number: Beyond Just the Price
For sophisticated investors, understanding how an unlisted valuation is derived is as important as the valuation figure itself. When you see a valuation of, say, ₹500 crores for a company you're considering, you should be asking:
- What growth rates were assumed for the next 5-7 years? Are they realistic given the market and competition?
- What discount rate was used? Does it appropriately reflect the risk profile of this specific company and its stage of development?
- Which comparable companies were chosen? Are they truly comparable, or are there significant differences in scale, profitability, or market position?
- What was the rationale for applying a particular multiple? Was a discount applied for illiquidity compared to public peers?
A good valuation report won't just give you a number; it will articulate the assumptions, sensitivities, and the 'why' behind the 'what'. This transparency is crucial for informed decision-making, especially when investing in private markets where liquidity is limited.
Illiquidity Discount: A Critical Factor
One element unique to unlisted valuations is the illiquidity discount. Public shares can be bought and sold daily. Unlisted shares, however, can be difficult to exit quickly. This lack of liquidity makes them inherently less valuable, all else being equal. A valuation for an unlisted company will often apply a discount to account for this. The size of this discount can vary significantly based on the company's stage, market conditions, and investor demand for its shares. Ignoring this can lead to an overestimation of your potential returns or, worse, a mispricing of your entry point.
Navigating Private Market Valuations with Neoma Capital
Sebi's review of the CAS methodology is a timely reminder that valuation, even for the most liquid instruments, is a complex science. For the less liquid, higher-growth unlisted space, it's even more critical to have a clear, defensible, and transparent valuation process.
At Neoma Capital, we believe that informed investing starts with a deep understanding of value. Our team provides strategic advisory services, including detailed [unlisted shares](link to /unlisted-shares) valuation insights, helping HNIs and family offices make sound decisions in the private markets. Whether you're assessing a pre-IPO opportunity or looking to understand the true worth of a private enterprise, having an expert perspective on valuation methodologies is invaluable.
Considering an investment in private markets and want to understand the valuation nuances? Talk to an advisor at Neoma Capital today.
Frequently Asked Questions
What is the primary difference between public and unlisted valuations?
Public valuations are driven by daily market supply and demand, reflecting sentiment and fundamentals, whereas unlisted valuations are typically based on fundamental analysis using methods like DCF or comparables, aiming for an intrinsic value without daily market price discovery.
How does the illiquidity discount affect unlisted valuations?
The illiquidity discount reduces the valuation of unlisted shares because they cannot be easily bought or sold compared to public shares. This discount accounts for the lack of quick exit options, making unlisted investments inherently less valuable on a per-share basis, all else being equal.
Can I trust a valuation provided by the company I'm investing in?
While the company's internal valuation can be a starting point, it's prudent for investors to seek an independent, third-party valuation or conduct their own due diligence. Company-provided valuations may sometimes be optimistic, making an objective assessment crucial for protecting your investment.
Are unlisted valuations fixed once they are done?
No, unlisted valuations are dynamic. They can change based on new financial performance, market conditions, industry trends, comparable company performance, and specific company milestones (e.g., new funding rounds, product launches). They should be periodically reviewed, especially for long-term investments.
This is educational content, not investment advice. Investments in securities are subject to market risks.